Resverlogix Corp. Stock OTC Markets
Stocks
RVXCF
CA76128M1086
Biotechnology & Medical Research
OTC Markets Traded|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.0734 USD | +2.79% |
|
-0.27% | -1.08% |
| 06-25 | Resverlogix Corp. - Shareholder/Analyst Call | |
| 05-15 | Resverlogix Corp. Reports Earnings Results for the First Quarter Ended March 31, 2026 | CI |
| Market Cap | 23.28M 16.58M 14.41M 13.45M 12.35M 1.58B 23.69M 159M 62.12M 788M 62.27M 60.89M 2.6B | P/E 2024 |
-1.38x | P/E 2025 | -2.68x |
|---|---|---|---|---|---|
| Enterprise Value | 109M 77.66M 67.49M 63.01M 57.85M 7.4B 111M 743M 291M 3.69B 292M 285M 12.18B | EV / Sales 2024 |
-
| EV / Sales 2025 | - |
| Free-Float |
60.4% | Yield 2024 * |
-
| Yield 2025 | - |
Last Transcript: Resverlogix Corp.
| 1 day | +2.79% | ||
| 1 week | -0.27% | ||
| Current month | +2.80% | ||
| 1 month | +10.04% | ||
| 3 months | -4.18% | ||
| 6 months | +39.54% | ||
| Current year | -1.08% |
| 1 week | 0.07 |  | 0.07 |
| 1 month | 0.06 | | 0.08 |
| Current year | 0.05 | | 0.1 |
| 1 year | 0.05 | | 0.1 |
| 3 years | 0.02 | | 0.21 |
| 5 years | 0.02 | | 0.65 |
| 10 years | 0.02 | | 4.14 |
| Manager | Title | Age | Since |
|---|---|---|---|
Donald McCaffrey
CEO | Chief Executive Officer | - | 2003-04-24 |
Anthony Cann
DFI | Director of Finance/CFO | 78 | 2009-10-28 |
| Chief Tech/Sci/R&D Officer | - | 2022-08-14 |
| Director | Title | Age | Since |
|---|---|---|---|
Donald McCaffrey
CHM | Chairman | - | 2016-04-03 |
Kelly McNeill
BRD | Director/Board Member | 56 | 2009-10-14 |
Kenneth Zuerblis
BRD | Director/Board Member | 66 | 2010-09-28 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +2.79% | -0.27% | - | - | 23.26M | |
| +0.05% | +3.08% | +38.17% | +66.77% | 56.7B | |
| +0.44% | -6.09% | +23.38% | +61.97% | 51.97B | |
| +1.84% | +1.27% | -14.06% | -13.50% | 23.33B | |
| -0.15% | -6.00% | -9.42% | +344.47% | 21.34B | |
| +2.23% | -1.21% | +33.31% | -25.52% | 17.44B | |
| +9.91% | -2.51% | +188.84% | +326.19% | 14.77B | |
| +3.83% | -1.34% | +47.77% | +165.22% | 13.84B | |
| +1.61% | +0.56% | +439.92% | +166.12% | 12.12B | |
| +3.14% | -12.56% | +59.51% | +149.39% | 11.14B | |
| Average | +2.24% | -2.33% | +89.72% | +137.90% | 24.74B | |
| Weighted average by Cap. | +1.26% | -1.95% | +57.83% | +109.50% |
| 2024 | 2025 | |
|---|---|---|
| Net sales | - | - |
| Net income | -7.64M -5.44M -4.72M -4.41M -4.05M -518M -7.77M -52.01M -20.37M -258M -20.42M -19.97M -852M | -7.77M -5.53M -4.81M -4.49M -4.12M -527M -7.9M -52.91M -20.72M -263M -20.77M -20.31M -867M |
| Net Debt | 81.87M 58.29M 50.66M 47.3M 43.42M 5.56B 83.3M 558M 218M 2.77B 219M 214M 9.14B | 85.79M 61.08M 53.09M 49.56M 45.5M 5.82B 87.29M 584M 229M 2.9B 229M 224M 9.58B |
Employees
-
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-08-03 | US$0.0734 | +2.79% | 13,850 |
| 26-07-28 | US$0.0714 | -3.00% | 9,080 |
- Stock Market
- Stocks
- RVX Stock
- RVXCF Stock
Select your edition
All financial news and data tailored to specific country editions
